• Users Online: 648
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2016  |  Volume : 28  |  Issue : 1  |  Page : 68-70

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma

Department of Ophthalmology, Government T D Medical College, Alappuzha, Kerala, India

Correspondence Address:
Prajina Rahul
Department of Ophthalmology, Government T D Medical College, Alappuzha, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0976-6677.193884

Rights and Permissions

Hepatitis C virus (HCV) is a blood-borne RNA virus that causes hepatitis C, chronic liver disease, and hepatocellular carcinoma. Patients with HCV infection are now treated with a combination of interferon alpha, which has antiviral and immunomodulatory properties, and ribavirin, an antiviral medication included in the family of nucleoside analogs. Recently, a long acting form of interferon alpha (pegylated interferon) has been developed, which has a more sustained antiviral response. One of the ocular side effects of interferon alpha is proliferative retinopathy related to ischemia. Interferon-associated retinopathy is usually mild and resolves completely, but occasionally, it can become severe.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded74    
    Comments [Add]    

Recommend this journal